Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 10, 2000, Pages 696-698

  Deal, C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; ESTROGEN; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; HUMAN; NOTE; OSTEOPOROSIS;

EID: 0033775202     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.10.696     Document Type: Note

References (15)

1. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis
2. Randomized trial of effect of alendronate on the risk of fracture in women with existing vertebral fractures
3. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
4. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
5. Thinking straight about calcium
6. Nutritional factors in osteoporosis
7. Does calcium supplementation prevent post menopausal bone loss? A double-blind, controlled clinical study
8. Vitamin D3 and calcium to prevent hip fractures in elderly women
9. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
10. Effect of calcium supplementation on bone loss in postmenopausal women
11. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
12. Treatment of postmenopausal osteoporosis with calcitriol or calcium
13. Secondary hyperparathyroidism in the elderly: Means to defining hypovitaminosis D
14. Consensus conference Osteoporosis